Kawasaki disease: Difference between revisions

(Created page with "==Diagnosis== A. Fever >38.5 (101.3) x >4dys AND B. 4 of the following: 1. Extremity edema/erythema/desquamation 2. Polymophous exanthem 3. Bilat conjunctiv...")
 
(Add peer-reviewed reference)
 
(66 intermediate revisions by 13 users not shown)
Line 1: Line 1:
==Diagnosis==
==Background==
*Also known as: mucocutaneous lymph node syndrome<ref>McCrindle BW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the AHA. Circulation. 2017;135(17):e927-e999. PMID 28356445</ref>
*[[Vasculitis]] of unknown etiology
**Likely a combination of genetic, infectious, and regional factors
*Peaks at 18-24 months
**Rare in <4mo, >5yr
*Leading cause of acquired heart disease in children
*Coronary aneurysm more common in incomplete than in classic KD
*[[MIS-C]] has a number of overlapping clinical features, but appears to be a separate diagnosis at this time.
{{Primary Vasculitis DDX}}


==Clinical Features==
[[File:PMC3232573 IPC-7-1-g014.png|thumb|[[Strawberry tongue]].]]
[[File:1200px-Kawasaki.png|thumb|Kawasaki disease signs]]
[[File:PMC5134159 IDOJ-7-461-g005.png|thumb|(a) Strawberry tongue; (b) Conjunctival injection; (c) Periungual desquamation.]]
*[[Fever]] that is high, abrupt. Anyone with a fever >5 days should be considered for a Kawasaki workup.
*[[Rash]] accompanies onset of fever
**Often seen in perineum. Presents as erythema and desquamation
**Later there are macular and morbilliform lesions on the trunk, arms, and legs
**No vescicles or bullae
**Maculopapular most common; vesicles not seen
*[[Conjunctivitis]]
**Bilateral and non-exudative in 90% of patients
**Anterior uveitis with cell and flare in 70% of patients but is more specific and suggestive of KD
*[[Mucositis]]: Cracked lips and strawberry tongue. Vesicles or ulcers suggest a pathology other than KD
*Edema of the hands and feet
**Desquamation around the nails in ~90%
*Lymphadenopathy is the least consistent finding in 50-75% of children
**Usually anterior cervical
**Less common in those under one year of age
*Cardiac complications develop early on
**Coronary artery aneurysm development is most prevalent as fever lessens
*KD shock syndrome (7%)


A. Fever >38.5 (101.3) x >4dys
===Associated Symptoms===
*Cardiac
**Coronary aneurysm
***Most develop during 3-4th week of illness
***May lead to MI (leading cause of death)
**[[Myocarditis]]/[[pericarditis]]
**[[Pericardial effusion]]
**LV dysfunction
**Valvular dysfunction
**[[Dysrhythmias]]
*Aseptic [[meningitis]]
*[[Urethritis]]
*[[Anemia]]
*[[RUQ pain]], large gallbladder (hydrops on US)


AND
==Differential Diagnosis==
{{Pediatric fever DDX}}
{{Erythematous rash DDX}}


B. 4 of the following:
==Evaluation==
===Work-Up===
*CBC
**[[Leukocytosis]]
**[[Thrombocytosis]]
*Labs
*[[LFTs]]- elevated
*ESR, CRP- elevated
*[[Blood culture]]
*[[Urinalysis]]
*[[ECG]]
*Viral panel: A positive viral PCR does not exclude KD
**42% of children with KD had a +viral respiratory panel on initial presentation
*[[Echocardiography|TTE]] (Coronaries, LV, valves)
**Consider if f ESR≥ 40, CRP≥ 3, or if desquamation occurs
*Red Top "Kawasaki Serum to CBR"


    1. Extremity edema/erythema/desquamation
===Evaluation===
*Clinical diagnosis
{| class="wikitable"
| align="center" style="background:#f0f0f0;"|'''Classic Kawasaki Disease'''
| align="left" style="background:#f0f0f0;"|Fever for 5 days or more '''plus''' four of the following symptoms
|-
| ||1. Bilateral nonexudative [[conjunctivitis]]
|-
| ||2. Mucous membrane changes (erythema, peeling, cracking of lips, "strawberry tongue," or diffuse oropharyngeal mucosal erythema)
|-
| ||3. Changes of the extremities (erythema or swelling of hands/feet, peeling of finger tips/toes in the convalescent stage)
|-
| ||4. [[Rash]]
|-
| ||5. Cervical adenopathy (more than one node >1.5 cm unusually unilateral anterior cervical)
|-
| '''Incomplete Kawasaki Disease'''||Fever for 5 days '''and''' two to three clinical criteria of classic Kawasaki disease '''plus'''
|-
| ||C-reactive protein 3.0 milligrams/L and/or erythrocyte sedimentation rate 40 mm/h '''plus''' positive echocardiogram '''or''' three or more of the following:
|-
| ||1. Albumin <3 grams/dL
|-
| ||2. [[Anemia]]
|-
| ||3. Elevated alanine aminotransferase (ALT)
|-
| ||4. Platelets >450,000/mm3 7d after fever onset
|-
| ||5. White blood cell count >12,000/mm3
|-
| ||6. Pyuria
|-
|}


    2. Polymophous exanthem
==Management==
Assess risk for IVIG resistance (There are 4 scoring systems):
{| class="wikitable"
! Scoring System !! Nation !! Enrolled patients !! IVIG resistance !! Sensitivity !! Specificity !! Risk Factors !! Point !! Predicted risk (score)
|-
| Egami || Japan || 320 || 41 || 78 || 76 || Age <6 mo || 1 || Low risk (0-2)
|-
|  ||  ||  ||  ||  ||  || Illness <4 days || 1 ||
|-
|  ||  ||  ||  ||  ||  || CRP 8+ mg/dL || 1 || High risk (3+)
|-
|  ||  ||  ||  ||  ||  || ALT 80+ mg/dL || 2 ||
|-
|  ||  ||  ||  ||  ||  || Platelets < 300 || 1 ||
|-
| Kobayashi || Japan || 528 || 148 || 86 || 68 || Age <12 mo || 1 || Low risk (0-3)
|-
|  ||  ||  ||  ||  ||  || Illness days <4 days || 2 ||
|-
|  ||  ||  ||  ||  ||  || CRP >10 mg/dL || 1 || High risk (4+)
|-
|  ||  ||  ||  ||  ||  || ALT >100 mg/dL || 2 ||
|-
|  ||  ||  ||  ||  ||  || Platelets < 300 || 1 ||
|-
|  ||  ||  ||  ||  ||  || Na <133  || 2 ||
|-
|  ||  ||  ||  ||  ||  || Neutrophils >80%  || 2 ||
|-
| San Diego || US || 362 || 60 || 73.3 || 61.9 || Illness <4 days || 1 || Low risk (0-1)
|-
|  ||  ||  ||  ||  ||  || GGT 60+ IU/L || 1 ||
|-
|  ||  ||  ||  ||  ||  || zHgb < -2 || 1 || High risk (2+)
|-
|  ||  ||  ||  ||  ||  || Bands >20 || 2 ||
|-
| Formosa || Taiwan || 248 || 29 || 86.2 || 81.3 || Lymphadenopathy || 1 || Low risk (0-2)
|-
|  ||  ||  ||  ||  ||  || Neutrophils >60% || 2 || High risk (3+)
|-
|  ||  ||  ||  ||  ||  || Albumin <3.5g/dL || 1 ||
|}


    3. Bilat conjunctival injection
*[[IVIG]] 2gm/kg over 12hr
 
**Requires inpatient monitoring for allergic reaction
    4. Lip/oral chages (red lips, straberry tongue)
**May increase ESR as IGs are positively charged which increases RBC sedimentation[1]
 
*[[Aspirin]]
    5. Cervical LAD (>1.5cm diam, usually unilat)
**30-100mg/kg/day divided 4 times a day is often used
 
**Has not been shown to prevent coronary artery aneurysms
*Also associated with platlets >1k
**3-5mg/kg/day is appropriate for anti-platelet activity
 
**[[Reye Syndrome]] has not been reported in association with KD treatment with aspirin
*[[Steroids]]
 
**For high-risk patients
CDC Dx criteria:
**Decreases CAA formation if started with IVIG
 
**Using it as a rescue for IVIG-resistant patients is less effective
Fever >5 days and 4/5 of:
 
Bilateral conjunctival injection
 
  limbic sparing
 
Oral mucosa changes
 
  erythema of lips or OR
 
  strawberry tongue
 
  dry cracked lips
 
Peripheral extremity changes
 
  edema
 
  erythema
 
  periungual desquamation
 
Rash
 
Cervical LAD >1.5cm
 
 
C- conjunctivitis
 
R- rash
 
A- aneurysm
 
S- strawberry tongue
 
H- hands feet changes
 
 
Associated Sx:
 
  High ESR/WBC/LFTs/Plts
 
  Aseptic meningitis
 
  Urethritis, Anemia
 
  RUQ pain, big GB (hydrops)
 
  Irritability, N/V/D
 
 
==Work-Up==
 
 
Labs:
 
  CBC/Diff/SPA/ALT/TBili
 
  Blood Cx and UA
 
  ECG
 
  Echo (Coronaries, LV, Valves)
 
  Red Top "Kawasaki Serum to CBR"
 
 
==Treatment==
 
 
Orders:
 
  Vitals:
 
    q6h pre ASA doses
 
    During IVIG/ Steroid Rx:
 
      q15min x1h
 
      q30min x1h
 
      q1h for remainder
 
      cardiac monitor during infsn
 
 
Consults:
 
  Full cardio
 
 
Meds:
 
  ASA 20mg/kg q6h until afebrile
 
  Benadryl 1mg/kg IV pre IVIG
 
  IVIG 2G/kg IV over 8-12h
 
  IV methylprednisolone 30mg/kg [max 1.5gm] over 3 hrs before IVIG
 
    pulse (shorter duration of fever, shorter hospital stay, lower ESR at 6 weeks.  Sundel et al, J Peds 142 June 2003)
 


==Disposition==
==Disposition==
*Admit
*Follow-up cardiac evaluation for coronary aneurysm screening




  F/U w/ cardio
==Medication Dosing==
 
*{{MedicationDose|drug=IVIG|dose=2 g/kg over 12hr|route=IV|context=Primary treatment|indication=Kawasaki disease|population=Pediatric|notes=Requires inpatient monitoring for allergic reaction}}
  Cont ASA at high dose, switch to ASA 3-5mg/kg/day once afebrile for 48h
*{{MedicationDose|drug=Aspirin|dose=30-100 mg/kg/day divided QID (acute), then 3-5 mg/kg/day (antiplatelet)|route=PO|context=Anti-inflammatory/antiplatelet|indication=Kawasaki disease|population=Pediatric|notes=Has not been shown to prevent coronary aneurysms; Reye syndrome not reported with KD treatment}}
 
 
==Source==
 
 
Adapted from Donaldson, Pani


==See Also==
*[[Pediatric fever]]
*[[MIS-C]]


==External Links==
*[https://www.cdc.gov/kawasaki/index.html CDC: Kawasaki Disease]


==References==
<References/>


[[Category:Peds]]
[[Category:Pediatrics]]
1. PMID: 24678327

Latest revision as of 10:16, 22 March 2026

Background

  • Also known as: mucocutaneous lymph node syndrome[1]
  • Vasculitis of unknown etiology
    • Likely a combination of genetic, infectious, and regional factors
  • Peaks at 18-24 months
    • Rare in <4mo, >5yr
  • Leading cause of acquired heart disease in children
  • Coronary aneurysm more common in incomplete than in classic KD
  • MIS-C has a number of overlapping clinical features, but appears to be a separate diagnosis at this time.

Vasculitis Syndrome Types

Clinical Features

Strawberry tongue.
Kawasaki disease signs
(a) Strawberry tongue; (b) Conjunctival injection; (c) Periungual desquamation.
  • Fever that is high, abrupt. Anyone with a fever >5 days should be considered for a Kawasaki workup.
  • Rash accompanies onset of fever
    • Often seen in perineum. Presents as erythema and desquamation
    • Later there are macular and morbilliform lesions on the trunk, arms, and legs
    • No vescicles or bullae
    • Maculopapular most common; vesicles not seen
  • Conjunctivitis
    • Bilateral and non-exudative in 90% of patients
    • Anterior uveitis with cell and flare in 70% of patients but is more specific and suggestive of KD
  • Mucositis: Cracked lips and strawberry tongue. Vesicles or ulcers suggest a pathology other than KD
  • Edema of the hands and feet
    • Desquamation around the nails in ~90%
  • Lymphadenopathy is the least consistent finding in 50-75% of children
    • Usually anterior cervical
    • Less common in those under one year of age
  • Cardiac complications develop early on
    • Coronary artery aneurysm development is most prevalent as fever lessens
  • KD shock syndrome (7%)

Associated Symptoms

Differential Diagnosis

Pediatric fever

Erythematous rash

Evaluation

Work-Up

  • CBC
  • Labs
  • LFTs- elevated
  • ESR, CRP- elevated
  • Blood culture
  • Urinalysis
  • ECG
  • Viral panel: A positive viral PCR does not exclude KD
    • 42% of children with KD had a +viral respiratory panel on initial presentation
  • TTE (Coronaries, LV, valves)
    • Consider if f ESR≥ 40, CRP≥ 3, or if desquamation occurs
  • Red Top "Kawasaki Serum to CBR"

Evaluation

  • Clinical diagnosis
Classic Kawasaki Disease Fever for 5 days or more plus four of the following symptoms
1. Bilateral nonexudative conjunctivitis
2. Mucous membrane changes (erythema, peeling, cracking of lips, "strawberry tongue," or diffuse oropharyngeal mucosal erythema)
3. Changes of the extremities (erythema or swelling of hands/feet, peeling of finger tips/toes in the convalescent stage)
4. Rash
5. Cervical adenopathy (more than one node >1.5 cm unusually unilateral anterior cervical)
Incomplete Kawasaki Disease Fever for 5 days and two to three clinical criteria of classic Kawasaki disease plus
C-reactive protein 3.0 milligrams/L and/or erythrocyte sedimentation rate 40 mm/h plus positive echocardiogram or three or more of the following:
1. Albumin <3 grams/dL
2. Anemia
3. Elevated alanine aminotransferase (ALT)
4. Platelets >450,000/mm3 7d after fever onset
5. White blood cell count >12,000/mm3
6. Pyuria

Management

Assess risk for IVIG resistance (There are 4 scoring systems):

Scoring System Nation Enrolled patients IVIG resistance Sensitivity Specificity Risk Factors Point Predicted risk (score)
Egami Japan 320 41 78 76 Age <6 mo 1 Low risk (0-2)
Illness <4 days 1
CRP 8+ mg/dL 1 High risk (3+)
ALT 80+ mg/dL 2
Platelets < 300 1
Kobayashi Japan 528 148 86 68 Age <12 mo 1 Low risk (0-3)
Illness days <4 days 2
CRP >10 mg/dL 1 High risk (4+)
ALT >100 mg/dL 2
Platelets < 300 1
Na <133 2
Neutrophils >80% 2
San Diego US 362 60 73.3 61.9 Illness <4 days 1 Low risk (0-1)
GGT 60+ IU/L 1
zHgb < -2 1 High risk (2+)
Bands >20 2
Formosa Taiwan 248 29 86.2 81.3 Lymphadenopathy 1 Low risk (0-2)
Neutrophils >60% 2 High risk (3+)
Albumin <3.5g/dL 1
  • IVIG 2gm/kg over 12hr
    • Requires inpatient monitoring for allergic reaction
    • May increase ESR as IGs are positively charged which increases RBC sedimentation[1]
  • Aspirin
    • 30-100mg/kg/day divided 4 times a day is often used
    • Has not been shown to prevent coronary artery aneurysms
    • 3-5mg/kg/day is appropriate for anti-platelet activity
    • Reye Syndrome has not been reported in association with KD treatment with aspirin
  • Steroids
    • For high-risk patients
    • Decreases CAA formation if started with IVIG
    • Using it as a rescue for IVIG-resistant patients is less effective

Disposition

  • Admit
  • Follow-up cardiac evaluation for coronary aneurysm screening


Medication Dosing

  • IVIG 2 g/kg over 12hr IV — Requires inpatient monitoring for allergic reaction
  • Aspirin 30-100 mg/kg/day divided QID (acute), then 3-5 mg/kg/day (antiplatelet) PO — Has not been shown to prevent coronary aneurysms; Reye syndrome not reported with KD treatment

See Also

External Links

References

  1. ↑ McCrindle BW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the AHA. Circulation. 2017;135(17):e927-e999. PMID 28356445

1. PMID: 24678327

Retrieved from "https://www.wikem.org/w/index.php?title=Kawasaki_disease&oldid=389609"